yingweiwo

Keap1-Nrf2

Keap1-Nrf2

Keap1-Nrf2 is the major regulator of cytoprotective responses to electrophilic chemicals or reactive oxygen species (ROS).Keap1 is an E3 ligase that triggers the ubiquitin-proteasome system (UPS) to degrade Nrf2. In cancer cells, upregulation of Nrf2 induced by Keap1 inactivation is frequently seen. Cancer cells' metabolism and proliferation are accelerated by aberrant Nrf2 activation. In this instance, Nrf2 is a desirable molecule to target therapeutically for the treatment of cancer, and numerous Nrf2 inhibitors are being developed. What's interesting is that Nrf2 induction is reportedly used as a treatment strategy to quicken the body's carcinogen detoxification process and prevent chemical carcinogenesis.

Keap1-Nrf2 related products

Structure Cat No. Product Name CAS No. Product Description
(S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) V82250 (S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) 2341796-79-8 (S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) is a synthetic E3 ligase (e.g. CRBN) ligand-linker conjugate containing VH032-based VHL ligand and 1 linker.
25-Hydroxycholesterol-d6 (25-Hydroxycholesterol-d6) V82232 25-Hydroxycholesterol-d6 (25-Hydroxycholesterol-d6) 88247-69-2 25-Hydroxycholesterol-d6 is the deuterated form of 25-Hydroxycholesterol.
3,4-二羟基苯甲酸甲酯 V31615 Methyl 3,4-dihydroxybenzoate 2150-43-8 Methyl 3,4-dihydroxybenzoate (Protocatechuic acid methyl ester) is the primary metabolite of antioxidant polyphenols found in green tea.
3-Methylhistamine dihydrochloride V82248 3-Methylhistamine dihydrochloride 36475-47-5 3-Methylhistamine di-HCl is a degradation product of histamine.
9,10-Dimethoxycanthin-6-one V82236 9,10-Dimethoxycanthin-6-one 155861-51-1 9,10-Dimethoxycanthin-6-one is an alkaloid compound that can inhibit NF-κB with IC50 of 19.5 μM.
9-Hydroxycanthin-6-one V82237 9-Hydroxycanthin-6-one 138544-91-9 9-Hydroxycanthin-6-one is an alkaloid compound that can inhibit NF-κB with IC50 of 3.8 μM.
AP-1/NF-κB activation inhibitor 1 V82244 AP-1/NF-κB activation inhibitor 1 188936-12-1 AP-1/NF-κB activation inhibitor 1 is a potent inhibitor of AP-1 and NF-κB-mediated transcription activation (IC50=1 μM) and does not block basal transcription driven by the β-actin promoter.
Coenzyme Q6 (Ubiquinone 30) V82231 Coenzyme Q6 (Ubiquinone 30) 1065-31-2 Coenzyme Q6 (Ubiquinone 30) is a prenylated benzoquinone lipid.
Fraxinellone analog 1 V89041 Fraxinellone analog 1 Fraxinellone analog 1 (compound 2) is an effective and rapid activator of the Nrf2-mediated antioxidant defense system, which has a protective effect on glutamate-mediated excitotoxicity and induces the expression of antioxidant genes Gpx4, Sod1 and Nqo1.
Ginger extract V82253 Ginger extract 84696-15-1 Ginger extract has anticancer, anti~inflammatory, and chemotherapeutic effects in animal models.
Goshonoside F5 V82238 Goshonoside F5 90851-28-8 Goshonoside F5 can be extracted from the immature fruits of Rubus chingii.
Gossypin V82251 Gossypin 652-78-8 Gossypin is a flavonoid extracted from Hibiscus vitifolius and has antioxidant, anti-inflammatory, anti-cancer, anti-aging, anti-diabetic and liver-protective activities.
Itaconic acid (Itaconic acid; Methylenesuccinic acid) V82241 Itaconic acid (Itaconic acid; Methylenesuccinic acid) 97-65-4 Itaconic acid is a precursor to synthetic polymers, chemicals and fuels that can be synthesized by fungi.
Keap1-Nrf2-IN-18 V87869 Keap1-Nrf2-IN-18 Keap1-Nrf2-IN-18 (Compound 22) is an orally active Keap1-Nrf2 protein-protein interaction (PPI) inhibitor with favorable pharmacokinetic (PK) properties and more potent in vivo activity in rats.
Keap1-Nrf2-IN-19 V87872 Keap1-Nrf2-IN-19 Keap1-Nrf2-IN-19 (compound 33) is an orally active Keap1-Nrf2 protein–protein interaction (PPI) inhibitor with a Kd of 0.0014 μM.
Keap1-Nrf2-IN-20 V87873 Keap1-Nrf2-IN-20 Keap1-Nrf2-IN-20 (Compound ZC9) is an inhibitor of the Keap-Nrf2 pathway with a KD2 of 51 nM.
Leukotriene E4-d5 (LTE4-d5) V82223 Leukotriene E4-d5 (LTE4-d5) 1240398-14-4 Leukotriene E4-d5 is the deuterated form of Leukotriene E4.
ML385 V2828 ML385 846557-71-9 ML-385 is a novel, potent and selective NRF2 inhibitor (Nrf2: nuclear factor E2 related factor 2) with an IC50 of 1.9 µM.
NF-κB-IN-11 V82230 NF-κB-IN-11 2768833-35-6 NF-κB-IN-11 (Compound 3i) is an NF-κB inhibitor.
NF-κB-IN-8 V82235 NF-κB-IN-8 2924565-59-1 NF-κB-IN-8 competitively antagonizes the binding of LPS to MD-2.
Contact Us